Saved Results

No results saved yet.

Enter a patient name and hit Save on a result.

tutorial
February 8, 2026
OncoToolkit Team

Original DIPSS for Primary Myelofibrosis

Source-locked guide to the original 2010 all-age DIPSS model for confirmed primary myelofibrosis.

Evidence-Based Guide

What this calculator implements

This calculator implements the original all-age Dynamic International Prognostic Scoring System (DIPSS) described by Passamonti and colleagues in 2010 for confirmed primary myelofibrosis. Unlike the baseline IPSS, DIPSS can be reassessed during the disease course.

Exact scoring

Constitutional symptoms are weight loss greater than 10% in 6 months, night sweats, or unexplained fever above 37.5 C. For longitudinal use, anemia must be persistent and not caused by treatment toxicity; other newly acquired factors should be disease-related.

| Score | Group | Historical median overall survival | | ---: | --- | --- | | 0 | Low | Median not reached | | 1-2 | Intermediate-1 | 14.2 years | | 3-4 | Intermediate-2 | 4.0 years | | 5-6 | High | 1.5 years |

These are historical original-cohort observations. Interpret them using elapsed time since diagnosis and only until the risk category changes. They are not individualized contemporary survival estimates.

Population and exclusions

Use the original DIPSS only for confirmed primary myelofibrosis. Do not apply this implementation to post-polycythemia-vera MF, post-essential-thrombocythemia MF, prefibrotic MF, treatment-toxicity-induced anemia, or predictors acquired for reasons unrelated to the disease.

No continuous hard minimum or maximum is added for age or laboratory values because the source does not define operational ranges beyond the published thresholds.

Related models are different

Baseline IPSS, age-adjusted DIPSS, DIPSS-Plus, MIPSS70 variants, and MYSEC-PM have different populations, variables, weights, or purposes. A result from this standalone calculator does not validate or substitute for those models.

Clinical interpretation

DIPSS is a prognostic aid, not a treatment or transplant directive. Document the assessment date and all five inputs, reassess when clinically appropriate, and make management decisions using the full clinical context and current guidance.

Open the original DIPSS calculator

Primary sources

  1. Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis. Blood. 2010;115(9):1703-1708. Primary publication
  2. PubMed record